Lundbeck and Otsuka’s Rexulti has become the first drug to be approved by the FDA to treat agitation associated with Alzheimer’s disease, a common symptom of the neurodegenerative disorder. The ...

And practical steps to exorcise the chemistry demons. Each fall brings ghosts, goblins and, if you’re not careful, a few monsters lurking right inside your plating tanks. They won’t knock on your door ...

As Lundbeck and Otsuka count on prescriptions in agitation associated with dementia due to Alzheimer’s disease (AADAD) to continue driving growth for Rexulti, the duo is supporting new research ...

Siddhant Sojitra, Alexion, defines in an AAPS PharmSci 360 2025 presentation an agitation model to reliably test stability for early-stage biologics. Mechanical stress testing is essential because ...

Agitation is the third most common neuropsychiatric symptom observed in patients with dementia, with 30% of patients exhibiting these symptoms; the frequency increases to 80% among patients living in ...

The Maratha quota protest in Mumbai has entered its fourth day, drawing tens of thousands of demonstrators to Azad Maidan, causing significant traffic disruptions and increased security measures ...

MUMBAI: Azad Maidan has become both a battlefield of resolve and a picture of squalor, as the Maratha quota agitation entered its third day on Sunday. Thousands of protesters, many of them farmers and ...

Aug 27 (Reuters) - BioXcel Therapeutics (BTAI.O), opens new tab said on Wednesday it plans to seek expanded approval early next year for use of its agitation drug at home after it succeeded in a ...

Regulatory submission to expand the label for Igalmi use in the outpatient setting is expected in the first quarter of 2026. At-home administration of dexmedetomidine sublingual film as a treatment ...

The word “anxiety” is often used to describe vastly different experiences that have different underlying causes and require markedly differing treatments. Here we describe two distinct presentations ...